Answers are grounded in this paper and cite their sources.
Background/Objectives: When several urine markers are abnormal during a hospital stay, it is unclear how often each finding recurs and how selective retesting affects the observed results. We examined short-term repeat confirmation in hospitalized adults with HIV in China and described urine albumin-to-creatinine ratio (UACR) reassessment after at least 3 months in the South African cohort of the African Research on Kidney Disease (ARK) study. Methods: The Chinese analysis included 543 adults. Generalized estimating equations (GEE) with inverse-probability-of-verification weighting (IPVW) estimated the association between concurrent dipstick abnormalities and confirmation of the same marker. Sensitivity analyses examined missing repeat outcomes and uncertainty from estimating the weights. Results: Of 168 patients with an initial abnormality, 83 were repeat-confirmed, 66 resolved, and 19 lacked an evaluable repeat outcome. The confirmation proportion was 55.7% among the 149 evaluable patients (83/149, exact 95% CI 47.3–63.8%). Confirmation was 26/38 (68.4%) with and 38/79 (48.1%) without a concurrent dipstick abnormality. The IPVW-GEE odds ratio (OR) was 4.81 (95% CI 1.34–17.26, p = 0.016). The two-stage jackknife sensitivity estimate had a wider interval (OR 4.805, 95% CI 1.009–22.877). In ARK, 28/50 retested participants had persistent albuminuria (56.0%, exact 95% CI 41.3–70.0%). Conclusions: The likelihood of short-term repeat confirmation varied across urinary markers and was higher when another dipstick marker was abnormal. The size of this association remains imprecise. ARK provides separate evidence on albuminuria persistence over a longer interval.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: